Skip to main content

Table 1 Correlations of both PDGF-BB and VEGF-C coexpression with clinicopathological factors in primary human NSCLC

From: Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer

  Factors P + V+ P-V- P1 P + V - P2 P-V+ P3
Gender Male 35 13 0.476 16 0.716 14 0.847
  Female 17 4   5   5  
Age >60 years 23 11 0.047 13 0.859 11 0.676
  ≤60 years 29 6   8   8  
Histology SQC 28 6 0.184 6 0.539 5 0.559
  ADC 24 11   15   14  
Tumor size >5 cm 24 3 0.037 5 0.950 6 0.563
  ≤5 cm 28 14   16   13  
differentiation WD, MD 35 17 0.017 17 0.757 12 0.027
  PD 17 0   4   7  
TNM stage I-IIa 12 8 0.113 10 0.973 8 0.765
  IIb-III 40 9   11   11  
Nodal status Positive 29 3 0.006 5 0.471 7 0.362
  Negative 23 14   14   12  
  1. Note: P1, P value between P + V + and P-V-; P2 , P value between P + V- and P-V-; P3, P value between P-V + and P-V-.
  2. Abbreviations: WD well differentiated, MD moderately differentiated, PD poorly differentiated, ADC adenocarcinoma, SQC squamous cell carcinoma.